Perspective Therapeutics (CATX) Non-Current Debt (2023 - 2026)
Perspective Therapeutics (CATX) posted Non-Current Debt of $1.6 million for Q1 2026, down 0.96% sequentially from $1.6 million in Q4 2025, and down 3.54% YoY from $1.6 million in Q1 2025.
Perspective Therapeutics (CATX) Non-Current Debt (2023 - 2026) Analysis & Trends
Perspective Therapeutics has reported Non-Current Debt for 4 years, with the latest figure at $1.6 million in Q1 2026.
- Quarterly Non-Current Debt fell 3.54% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 3.54% YoY) and the FY2025 annual result came in at $1.6 million, down 3.45% from the prior year.
- Non-Current Debt declined to $1.6 million in Q1 2026 per CATX's latest filing, from $1.6 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $1.7 million in Q3 2023 and troughed at $1.6 million in Q1 2026.
- A 4-year average of $1.6 million and a median of $1.6 million in 2024 frame the typical range for Non-Current Debt.
- The widest YoY moves for Non-Current Debt: up 2.92% in 2024, down 5.7% in 2024.
- Over 4 years, Non-Current Debt stood at $1.7 million in 2023, then decreased by 3.04% to $1.6 million in 2024, then dropped by 3.45% to $1.6 million in 2025, then fell by 0.96% to $1.6 million in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $1.6 million, $1.6 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Perspective Therapeutics | 389.10 Mn | 389.10 Mn | - | 1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.54 Mn |
| Mar 31, 2026 | 1.55 Mn |
| Dec 31, 2025 | 1.57 Mn |
| Sep 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | 1.60 Mn |
| Mar 31, 2025 | 1.61 Mn |
| Dec 31, 2024 | 1.63 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.65 Mn |
| Mar 31, 2024 | 1.66 Mn |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | 1.74 Mn |
| Jun 30, 2023 | 1.70 Mn |
| Mar 31, 2023 | 1.71 Mn |